Program
May 24
Time: 11.00 – 13.00
Registration
Time: 13.00 – 13.15
Presenter: Lars Grundemar
Welcome and introduction
Affiliation
Lund University, Sweden
Session on Immune therapy, cancer and COVID-19
Chairs: Karin Lindkvist, Lund University, Sweden
Kristian Pietras, Lund University, Sweden
Time: 13:15 – 13:45
Presenter: Mikael Dolsten
Keynote presentation
New frontiers in designing medicines and vaccines to combat human disease.
Affiliation
Lund University, Sweden/Pfizer, USA
Time: 13:45 – 14:30
Presenter: Robert Langer
Distinguished Service Award Lecture: Delivery systems for macromolecules and nucleic acids: from enabling the isolation of angiogenesis inhibitors to the development of mRNA vaccines
Affiliation
Massachusetts Institute of Technology, MA, USA
Time: 14:30 – 14:50
Presenter: Fredrik Tiberg
Novel long-acting medications based on lyotropic liquid crystals
Affiliation
Camurus AB, Lund, Sweden
Time: 14:50 – 15.25
COFFEE BREAK
Time: 15:25 – 16:10
Presenter: Drew Weissman
Therapeutic Achievement Award Lecture: Nucleoside-Modified mRNA-LNP Therapeutics
Affiliation
University of Pennsylvania, PA, USA
Time: 15:25 – 16:10
Presenter: Drew Weissman
Therapeutic Achievement Award Lecture: Nucleoside-Modified mRNA-LNP Therapeutics
Affiliation
University of Pennsylvania, PA, USA
Time: 16:10 – 16:40
Presenter: Dario Neri
From encoded combinatorial libraries to clinical-stage targeted therapeutics
Affiliation
ETH Zürich, Switzerland and Philogen, Italy
Time: 16:40 – 17:00
Presenter: Thoas Fioretos
Exploring Leukemia Stem Cells as Models for New Treatment Options in Cancer: From the bench to clinical trials
Affiliation
Lund University, Sweden
Time: 17:00 – 17:20
Presenter: Lars Björck
Bacterial proteins interacting with human antibodies as drugs and tools in biomedical industry and research
Affiliation
Lund University, Sweden
Time: 19:00
SPEAKERS DINNER
HYPOTEKSFÖRENINGEN
May 25
Continued: Session on Immune therapy, cancer and COVID-19
Chairs: Göran Jönsson, Lund University, Sweden
Filipe Pereira, Lund University, Sweden
Time: 9:00 – 9:30
Presenter: Stephen W. Fesik
Fragment-based drug discovery
Affiliation
Vanderbilt University, TN, USA
Time: 9:30 – 9:50
Presenter: Kirill Popov
Integrating Weak Affinity Chromatography into the lead generation toolbox
Affiliation
Red Glead Discovery AB, Sweden
Time: 10:10 – 10:45
COFFEE BREAK
Session on Neuro, cardiovascular, metabolism & new modalities
Time: 10:45 – 11:15
Presenter: Claes Wahlestedt
Keynote presentation
Genome-informed therapeutics
Affiliation
University Miami, FL, USA
Time: 11:15 – 12:00
Presenter: Jude Samulski
Sune Bergström Award Lecture: Adeno-associated Virus Gene Therapy & the Emergence of Molecular Medicine: a 40-year Journey
Affiliation
University of North Carolina, NC, USA
Time: 12:00 – 13:15
LUNCH
Tegners matsalar
Continued: Session on Neuro, cardiovascular, metabolism & new modalities
Chairs: Åsa Petersen, Lund University, Sweden
Ulrik Gether, University of Copenhagen, Denmark
Time: 13:15 – 13:45
Presenter: David Julius
Probing cellular mechanisms of visceral nociception
Affiliation
University of California, San Francisco, CA, USA
Time: 13:45 – 14:30
Presenter: Sarah Tabrizi
The Arvid Carlsson Award Lecture: New genetic therapies for neurodegenerative disease
Affiliation
University College London, UK
Time: 14:30 – 14:50
Presenter: Tomas Björklund
Accelerating development of gene therapy using AI and machine learning
Affiliation
Lund University, Sweden
Time: 14:50 – 15:10
Presenter: Sara Snogerup Linse
Can kinetics-based discovery provide new therapeutic strategies against amyloid diseases?
Affiliation
Lund University, Sweden
Time: 15:10 – 15:40
COFFEE BREAK
Time: 15:40 – 16:25
Presenter: Brian Kobilka
The Bengt Samuelsson Award Lecture: G Protein Coupled Receptors: Challenges and New Approaches to Drug Discovery
Affiliation
Stanford University, CA, USA
Time: 16:25 – 16:55
Presenter: Kristian Strömgaard
Targeting receptor complexes with peptide-based drug modalities
Affiliation
University of Copenhagen, Denmark
Time: 16:55 – 17:15
Presenter: Trevor Forsyth
Biophysical approaches for the study of transthyretin amyloidosis and drug design
Affiliation
LINX, Lund University, Sweden
Time: 17:15 – 18:15
Poster session with refreshments, at Palaestra
Time: 18:30 – 19:30
Reception at Grand Hotel
Time: 19.30
Conference dinner Grand Hotel
May 26
Session on neuro, metabolism, CV & new modalities, continued
Chairs: Dan Larhammar, Uppsala University, Sweden
Ulf Ellervik, Lund University, Sweden
Time: 9:00 – 9:45
Presenter: Craig Crews
Award for Special Achievement Lecture: PROTAC-mediated Protein Degradation: A New Therapeutic Modality
Affiliation
Yale University, CT, USA
Time: 9:45 – 10:05
Presenter: Tariq Sethi
Targeting galectin-3 in fibrotic disease
Affiliation
Red Glead Discovery AB, Sweden
Time: 10:05 – 10:25
Presenter: Björn Walse
Structural biology in industry
Affiliation
SARomics Biostructures AB, Sweden
Time: 10:25 – 11:00
COFFEE BREAK
Time: 11:00 – 11:30
Presenter: Jennifer Petter
Targeting RNA with Small Molecules Using Structure-based Drug Design
Affiliation
Arrakis Therapeutics, MA, USA
Time: 11:30 – 12:00
Presenter: Charlotte Allerton
Designing for Therapeutic Success
Affiliation
Pfizer Inc., USA
Time: 12:00 – 12:05
Presenter: Organizing committee
FINAL REMARKS!
Time: 12:05
LUNCH
